Delivery Order SPE2DB20D2104-SPE2DB23FU51C
- Not listed
- This federal contract award, valued at $12,976.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Ramipril 10 mg capsules, a medication used to treat high blood pressure and heart failure. The contract has an ultimate completion date of March 8, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $2,525.16 Firm Fixed Price Delivery Order for the supply of RAMIPRIL 10 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of July 1, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,387.28 firm fixed-price delivery order is for the supply of 500 capsules of Ramipril 10 mg, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award, valued at $2,879.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This delivery order is for 4,563,273,583 units of the medication Ramipril 10 mg capsules, which are used to treat...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,229.57 firm fixed price delivery order is for the supply of 4554485288 units of Ramipril 10 mg capsules. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This single-award IDC serves as...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ramipril 10 mg capsules. The contract is a Delivery Order with a Firm Fixed Price and a ceiling value of $1,007.38. It does not have a set-aside designation. The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,543.29 firm fixed-price delivery order is for the supply of 100 capsules of the medication Ramipril 10 mg. The contract has an ultimate completion date of May 8, 2025 and was awarded on May 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by...
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order with a Firm Fixed Price for the supply of RAMIPRIL 5 MG CAPSULE 500S, awarded by the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,438.71 and a completion date of July 2, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the Defense...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of RAMIPRIL 2.5 MG CAPSULE 500S, a medication, with a ceiling value of $1,441.21. The contract is a Firm Fixed Price Delivery Order with a period of performance ending on July 11, 2025. This award is not associated with a set-aside program, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ramipril 10 mg capsules. The $3,896.40 firm fixed price contract has an ultimate completion date of August 22, 2024. As this is a delivery order, it is likely part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 for the supply of a comprehensive range of medical...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FU51CDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,727.69, is for the delivery of Ramipril 10 mg capsules. This is a Firm Fixed Price Delivery Order contract with a completion date of July 24, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award was not designated with any set-aside requirements, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 7/21/23 |